BioCentury
ARTICLE | Company News

ExonHit, RedPath deal

May 3, 2010 7:00 AM UTC

ExonHit will acquire RedPath for $12.5 million in cash and $10 million in ExonHit stock. RedPath shareholders are also eligible for up to $9.5 million in sales-based milestones starting in 2012. RedPa...